Authors
Latest:
Evan Rieder, MD: Equipping Patients With Tools for Skin AcceptanceFollowing this week's Science of Skin media roundtable hosted by AbbVie, panelist and dual-board certified dermatologist and psychiatrist Evan Rieder, MD, discusses the relationship between chronic skin conditions and mental health.
Latest:
Select Medical Software Based on Your Practice’s Life Cycle StageThough providers probably can use any type of medical software, the financial resources they are able to invest in medical solutions differ significantly based on the type of practice.
Latest:
Addressing Cutaneous Blisters and Chronic Bullous Disorders With Megan Noe, MD, MPH, MSCEMegan Noe, MD, MPH, MSCE, reviews best practices for treating patients with cutaneous blisters and managing chronic bullous disorders.
Latest:
Q&A: Late-Breaking REMIX-1 and REMIX-2 Data Demonstrated Efficacy of Remibrutinib in Chronic Spontaneous UrticariaAllergist immunologist Giselle Mosnaim, MD, recently spoke with Dermatology Times to discuss late-breaking phase 3 REMIX-1 and REMIX-2 data presented at the American Academy of Allergy, Asthma, and Immunology Annual Meeting.
Latest:
In Skin Cancer, Immunotherapy May Lead to Chronic EffectsResearch showed that many patients with skin cancer who had been treated using immunotherapy, such as immune checkpoint inhibition, experienced chronic side effects.
Latest:
Insight from Anant Madabhushi, PhD on AI in Dermatologic CareHis keynote speech at ACMS focused on artificial intelligence for precision medicine and cancer diagnosis.
Latest:
Vitiligo Case Report: A 9-Year Old Patient With White Macules, Halo NevusJordan Bui and Bernard A. Cohen, MD, review a case of a young patient with vitiligo.
Latest:
Acknowledging Opportunities for Further Research in AD ManagementDavid Rosmarin, MD, acknowledges opportunities for further research in diverse populations to continue updating AD treatment guidelines.
Latest:
Addressing Disparities in Skin-Aging Prevention Among Women of ColorA recent survey covered topics including skin-aging prevention, care-seeking behavior, trust in professionals, and more.
Latest:
Rad Quotes From RAD 2023Experts in the field share why they enjoyed the 5th Annual Revolutionizing Atopic Dermatitis Conference and why it is unique.
Latest:
Pharmacists Play Crucial Role in Advising Patients With Androgenetic AlopeciaPharmacists play a role in advising patients with hair loss about self-management and proper application of over the counter products.
Latest:
Skin of Color Considerations in AestheticsCheryl Burgess, MD, will share pearls on counseling patients on appropriate cosmetic procedures for their skin type, safety measures, and strategies to achieve desired outcomes.
Latest:
Overview of Prurigo Nodularis for Practicing Dermatology CliniciansIt is crucial to better understand, diagnose, and manage this skin condition associated with significant quality-of-life impairment.
Latest:
Dermatologic differences in a diverse populationUnderstanding the difference in biology and clinical presentations of cutaneous conditions in different skin types is critical for health care professionals to treat a diverse population.
Latest:
The Latest Updates in Isotretinoin With Emmy Graber, MDGraber discusses isotretinoin dosing and monitoring pearls at SCALE 2023.
Latest:
Utilizing Multidisciplinary Solutions for ItchSonya Kenkare, MD, explains her approach to itch and the support system of multiple specialties to help a pediatric patient with atopic dermatitis.
Latest:
Aircrews Face Increased Risk of Developing Skin CancerFrequent fliers, including pilots and cabin crew, are exposed to greater levels of UV and cosmic ionizing radiation than the general population, leading to higher incidence of skin cancers.
Latest:
Frontline Forum Part 4: Improving Basal Cell Carcinoma ManagementIn the final part of this Frontline Forum series, Brent Moody, MD; Sarah Arron, MD, PhD; Justine Cohen, DO; Emily Ruiz, MD, MPH; and Todd Schlesinger, MD, review 4 real-world clinical cases of BCC and the treatments they utilized.
Latest:
Atezolizumab Combo Results in Intracranial Activity in BRAFV600+ MelanomaSecond-line end points of the TRICOTEL trial assessing atezolizumab plus vemurafenib and cobimetinib in melanoma with central nervous system metastases appear consistent with primary efficacy end points.
Latest:
Treatment of Plaque Psoriasis in ChildrenA variety of topicals and biologics are now available to treat children affected by this challenging condition.
